Relic Technologies Announces Quarterly Financial Results: Standalone and Consolidated Performance Update
Relic Technologies Limited has released its unaudited financial results for the quarter ended June 30, 2026, providing detailed snapshots of both standalone and consolidated performance. The company's operational updates include commencing revenue from operations across pharmaceuticals, nutraceuticals, wellness products, healthcare products, chemicals, and allied products during this period.The financial data, prepared in Lakhs, is available for review and includes comparison figures for the preceding quarters and the full fiscal year ended March 31, 2026.
Standalone Financial Results Summary (Quarter Ended June 30, 2026)
The standalone results show Net Profit for the quarter ending June 30, 2026, at 21.47 Lakhs. Total Income stood at 64.15 Lakhs.Key figures from the Statement of Standalone Unaudited Financial Results are presented below:
| Metric | Quarter Ended June 30, 2026 (Unaudited) | Quarter Ended March 31, 2026 | Quarter Ended June 30, 2025 (Unaudited) | Year Ended March 31, 2026 (Audited) |
|---|---|---|---|---|
| Total Income | 64.15 | 37.41 | 22.92 | 130.18 |
| Total Expenses | 41.98 | 22.87 | 13.17 | 70.95 |
| Net Profit for the period | 21.47 | 9.49 | 9.84 | 54.20 |
| Total Comprehensive Income | 21.47 | 9.49 | 9.84 | 54.20 |
The company's paid up equity share capital was reported at 559.12 Lakhs for the quarter ending June 30, 2026. Earnings Per Share (Basic) for the period was noted at 0.38.
Consolidated Financial Results Overview
The consolidated results reflected revenues of 57.86 Lakhs in the quarter ended June 30, 2026. However, the company reported a loss attributable to Owners of the Parent for the quarter, and also faced losses across previous comparative periods.A summary of the Consolidated Unaudited Financial Results is provided below:
| Metric | Quarter Ended June 30, 2026 (Unaudited) | Quarter Ended March 31, 2026 | Quarter Ended June 30, 2025 (Unaudited) | Year Ended March 31, 2026 (Audited) |
|---|---|---|---|---|
| Total Income | 57.86 | 65.85 | 145.72 | 341.45 |
| Net Profit for the period/year (Consolidated) | (102.75) | (293.70) | (368.32) | (694.49) |
| Total Comprehensive Income | (101.28) | (293.20) | (368.32) | (692.94) |
| Loss attributable to Owners of the Parent | (64.88) | (201.23) | (323.76) | (536.92) |
The company's subsidiary entities contributing to the consolidated results include Relic Pharma Limited and Truhealthy Wellness Private Limited. The unaudited interim financial results of two subsidiaries reflected total revenues of 14.34 Lakhs, with a net profit/loss after tax of (124.22) Lakhs for the quarter ended June 30, 2026.
Stock Price Movement
As of 12:18, Relic Technologies Ltd. is currently trading steady at ₹67.99, maintaining a zero percentage change in its shares. The stock remains completely flat as the intraday high and low both stand precisely at ₹67.99.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.